Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From DNA repair to neurodegeneration: PARP1 mechanisms and inhibitor strategies in Alzheimer's disease.

DNA repair·2026

Same author

Behavioral attenuation of marble burying and digging mirrors evoked and non-evoked phenotypes in the endometriosis mouse model.

Scientific reports·2026

Same author

Enhanced central histaminergic transmission via H<sub>1</sub> and H<sub>2</sub> receptor alleviates the behavioral despair, reduction in BDNF and pCREB levels in streptozotocin-induced diabetic mice.

Behavioural brain research·2026

Same author

T2 hypointense lesions of the abdomen: imaging spectrum and diagnostic considerations.

Abdominal radiology (New York)·2026

Same author

Defining Quality of Life: The Perspective of People Living with Parkinson's Disease.

Movement disorders clinical practice·2026

Same author

Plant-Based Oral Vaccines: Molecular Biotechnology Approaches Toward Functional Food-Based Immunization.

Molecular biotechnology·2026

Search research articles

Related Experiment Video

Updated: Jan 2, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Diabetes and Cardiovascular Disease: an Update.

Rajaa Almourani¹, Bhavana Chinnakotla¹, Richa Patel¹

¹Department of Medicine, Division of Endocrinology, University of Missouri, Columbia, MO, USA.

Current Diabetes Reports

|December 13, 2019

Summary

Cardiovascular disease is a major risk for people with diabetes. Managing diabetes requires focusing on cardiovascular risk reduction with glucose-lowering agents and other therapies, not just glycemic control.

Keywords:

Cardiovascular disease Diabetes Dyslipidemia Hypertension Legacy effect Memory effect

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Jan 2, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Area of Science:

Endocrinology
Cardiology
Pharmacology

Background:

Cardiovascular disease (CVD) is the primary cause of death in individuals with diabetes.
Effective management strategies for diabetes must address the high risk of CVD.

Purpose of the Study:

To review the pathophysiology of CVD in diabetes.
To examine landmark clinical trials related to CVD in diabetes.
To discuss the cardiovascular benefits of glucose-lowering agents and anti-platelet therapies.

Main Methods:

Literature review of pathophysiology.
Analysis of landmark clinical trials.
Discussion of current treatment guidelines and emerging evidence.

Main Results:

Statins are recommended for all diabetic patients over 40, irrespective of LDL levels, due to proven cardiovascular benefits.
Blood pressure targets below 130/80 mmHg are advised for high-risk individuals.
Multifactorial risk reduction, including lipid-lowering and antihypertensive agents, is crucial.

Conclusions:

Glycemic control alone is insufficient for optimal diabetes management.
Glucose-lowering agents with demonstrated cardiovascular benefits should be initiated early.
Comprehensive cardiovascular risk reduction is essential for patients with diabetes.